Chlorprothixene - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for chlorprothixene and what is the scope of patent protection?
Chlorprothixene
is the generic ingredient in one branded drug marketed by Roche and is included in three NDAs. Additional information is available in the individual branded drug profile pages.Summary for chlorprothixene
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 62 |
Clinical Trials: | 3 |
Patent Applications: | 6,901 |
DailyMed Link: | chlorprothixene at DailyMed |
Recent Clinical Trials for chlorprothixene
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Hannover Medical School | Phase 3 |
Drug Safety and Effectiveness Network, Canada | |
Canadian Institutes of Health Research (CIHR) |
Medical Subject Heading (MeSH) Categories for chlorprothixene
Anatomical Therapeutic Chemical (ATC) Classes for chlorprothixene
US Patents and Regulatory Information for chlorprothixene
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | TARACTAN | chlorprothixene | CONCENTRATE;ORAL | 016149-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Roche | TARACTAN | chlorprothixene | TABLET;ORAL | 012486-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Roche | TARACTAN | chlorprothixene | TABLET;ORAL | 012486-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |